Rosetta Genomics (ROSG) Posts Q4 Adj-Loss of 20c
Tweet
Share
E-mailGet Alerts ROSG Hot Sheet
Join SI Premium – FREE
Rosetta Genomics (Nasdaq: ROSG) reports Q4 adj-loss of $0.20, versus a loss of $0.25 reported for the same period a year ago. Revenue for the quarter was $45,000, compared to $119,000 in Q409.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- AXIL Brands (AXIL) Tops Q4 EPS by 4c
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
